The use of molecular imaging to determine which patient should receive which targeted therapy
How can germline mutations distinguish risk for lethal and indolent prostate cancer?
The challenges facing the development of molecular imaging modalities in targeted cancer therapy
The reasons behind the success of Benjamin’s Brothers
Is it possible to destroy the cancer while preserving the prostate?